Zobrazeno 1 - 10
of 13
pro vyhledávání: '"J. D. Gemmill"'
Autor:
Gordon D.O. Lowe, Jessie T. Douglas, W.S. Hillis, A.P. Rae, Francis G. Dunn, J D Gemmill, Karen Hogg
Publikováno v:
European Heart Journal. 14:819-825
The incidence, amplitude, mechanism and relationship to prior exposure to streptococcal antigen of blood pressure changes to streptokinase-containing thrombolytic agents were investigated in 125 patients treated with either 1.5 x 10(6) IU streptokina
Publikováno v:
Circulation. 87:401-405
BACKGROUND Sumatriptan (GR43175) is a selective 5-hydroxytryptamine (5HT1) receptor agonist effective in the acute treatment of migraine. Recent in vitro experiments suggest that it has vasoactive properties in vascular beds distinct from the cerebra
Publikováno v:
Vascular Medicine Review. :146-155
Autor:
A P Rae, J.M.A. Burns, F G Dunn, W S Hillis, R Fears, E. Glasgow, H Ferres, J D Gemmill, R. Standring, Karen Hogg
Publikováno v:
Heart. 68:167-170
Objective —To examine the induction of antistreptokinase antibodies after giving streptokinase or anistreplase to patients with acute myocardial infarction. Design —Patients were randomly allocated to receive either 1·5 × 10 6 IU, streptokinase
Autor:
H. S. Rasmussen, W.S. Hillis, Andrew W. Kelman, PA Meredith, HL Elliott, J. D. Gemmill, C. A. Howie
Publikováno v:
British Journal of Clinical Pharmacology. 32:429-432
1. UK-68,798, a novel class III anti-arrhythmic agent was administered intravenously to twelve healthy volunteers in a placebo controlled, double-blind, dose-escalating study. 2. Doses of 5 and 10 micrograms kg-1 of UK-68,798 selectively and signific
Publikováno v:
Heart. 66:134-138
OBJECTIVE--To examine the efficacy, safety, and the pharmacokinetic profile of a bolus dose administration regimen of alteplase in the treatment of acute myocardial infarction. DESIGN--An open pilot study. SETTING--District general hospital. PATIENTS
Publikováno v:
The Lancet. 335:254-258
128 patients with acute myocardial infarction of duration 6 h or less were randomised in double-blind fashion to receive 30 U anistreplase over 5 min or 1·5 MU streptokinase over 1 h, both intravenously. Angiographic patency was assessed 90 min and
Publikováno v:
British heart journal. 72(3)
OBJECTIVE--To evaluate the influence of pretreatment streptokinase resistance titre and the concentration of IgG antibodies to streptokinase on the efficacy of thrombolytic drugs containing streptokinase in restoring coronary patency in acute myocard
OBJECTIVE--To assess the clinical ability of general practitioners to decide to give thrombolytic therapy to patients with suspected myocardial infarction and to assess the contribution of the electrocardiograph (ECG) to this decision-making process.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c16b6bf87b0ed0eba3a3bb1b0d8a525
https://europepmc.org/articles/PMC1025379/
https://europepmc.org/articles/PMC1025379/
Publikováno v:
British journal of clinical pharmacology. 32(2)
1. The transpulmonary pharmacokinetics of the intravenous diacid ACE inhibitor perindoprilat were studied in 10 male patients undergoing diagnostic cardiac catheterisation for the management of ischaemic heart disease. 2. Following successful complet